example

inferred list

DrugTargetPrediction<br> scoreInteraction type<br> [drug - target]
D00293, Diazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha21known
D00293, Diazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha51known
D00293, Diazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma21known
D00293, Diazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9986known
D00293, Diazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9968known
D00293, Diazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9968known
D00293, Diazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9961known
D00293, Diazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9913known
D00293, Diazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9908known
D00293, Diazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9837known
D00293, Diazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9814known
D00293, Diazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9805known
D00365, Lorazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9742known
D00365, Lorazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9733known
D00370, Temazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9726known
D00365, Lorazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9724known
D00365, Lorazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.972known
D00370, Temazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9705known
D00365, Lorazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9701known
D00370, Temazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9696known
D00365, Lorazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9695known
D00387, Triazolam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9694known
D00370, Temazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9683known
D00370, Temazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9681known
D00365, Lorazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9678known
D00387, Triazolam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9675known
D00293, Diazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9674known
D00293, Diazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9672known
D00370, Temazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9666known
D00387, Triazolam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9665known
D00370, Temazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9659known
D00225, Alprazolam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9655known
D00387, Triazolam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9653known
D00387, Triazolam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9649known
D00387, Triazolam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9636known
D00387, Triazolam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9628known
D00370, Temazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9628known
D00365, Lorazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9624known
D00370, Temazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9622known
D00365, Lorazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9618known
D00225, Alprazolam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9618known
D00225, Alprazolam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9609known
D00225, Alprazolam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9609known
D00387, Triazolam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9596known
D00293, Diazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9596known
D00225, Alprazolam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9595known
D00387, Triazolam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9591known
D00225, Alprazolam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9579known
D00225, Alprazolam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9572known
D00225, Alprazolam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9557known
D00370, Temazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9554known
D00225, Alprazolam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9552known
D00365, Lorazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9549known
D00365, Lorazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9543known
D00370, Temazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9531known
D00365, Lorazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9526known
D00387, Triazolam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9522known
D00370, Temazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9508known
D00329, Flurazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.95known
D00387, Triazolam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9499known
D00329, Flurazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9493known
D00225, Alprazolam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9485known
D00329, Flurazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9485known
D00387, Triazolam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9478known
D00457, Quazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9474known
D00329, Flurazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9472known
D00311, Estazolam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9463known
D00225, Alprazolam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9462known
D00311, Estazolam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9455known
D00329, Flurazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9455known
D00329, Flurazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9454known
D00329, Flurazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9448known
D00311, Estazolam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9442known
D00457, Quazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9439known
D00311, Estazolam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9438known
D00457, Quazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9429known
D00457, Quazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9429known
D00311, Estazolam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9424known
D00225, Alprazolam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9421known
D00311, Estazolam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9418known
D00457, Quazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9416known
D00280, Clonazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9406known
D00329, Flurazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9402known
D00457, Quazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9401known
D00329, Flurazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9397known
D00370, Temazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9396known
D00457, Quazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9393known
D00311, Estazolam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9393known
D00370, Temazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9393known
D00365, Lorazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9392known
D00365, Lorazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9389known
D00457, Quazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9378known
D00457, Quazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9373known
D00280, Clonazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9366known
D00387, Triazolam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9365known
D00387, Triazolam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9362known
D00280, Clonazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9361known
D00280, Clonazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9357known
D00280, Clonazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9344known
D00311, Estazolam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.934known
D00311, Estazolam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9335known
D00470, Prazepam hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9331known
D00329, Flurazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.933known
D00280, Clonazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9328known
D00225, Alprazolam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9325known
D00225, Alprazolam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9324known
D00280, Clonazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.932known
D00370, Temazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9319known
D00470, Prazepam hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9318known
D00365, Lorazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9316known
D00430, Secobarbital hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.9312known
D00280, Clonazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.931known
D00470, Prazepam hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.931known
D00329, Flurazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9308known
D00457, Quazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9307known
D00280, Clonazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9305known
D00329, Flurazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.93known
D00470, Prazepam hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9297known
D00430, Secobarbital hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9289known
D00387, Triazolam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9288known
D00470, Prazepam hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9287known
D00457, Quazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9284known
D00470, Prazepam hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9281known
D00430, Secobarbital hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9281known
D00470, Prazepam hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9274known
D00311, Estazolam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.927known
D00430, Secobarbital hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.9268known
D00311, Estazolam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9267known
D00430, Secobarbital hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9267known
D00430, Secobarbital hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9252known
D00225, Alprazolam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.925known
D00454, Olanzapine hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.9248known
D00457, Quazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9247known
D00311, Estazolam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9246known
D00430, Secobarbital hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9245known
D00280, Clonazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.924known
D00470, Prazepam hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9236known
D00470, Prazepam hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9231known
D00280, Clonazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9218known
D00430, Secobarbital hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9217known
D00430, Secobarbital hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9212known
D00067, Estrone hsa:2099, (RefSeq) estrogen receptor 10.9188known
D00067, Estrone hsa:2100, (RefSeq) estrogen receptor 20.9181known
D00329, Flurazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9175known
D00280, Clonazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9175known
D00329, Flurazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9173known
D00470, Prazepam hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9165known
D00457, Quazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9152known
D00499, Pentobarbital hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.915known
D00457, Quazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9149known
D00430, Secobarbital hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.9146known
D00470, Prazepam hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9143known
D00470, Prazepam hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.9129known
D00430, Secobarbital hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.9124known
D00499, Pentobarbital hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.9121known
D00311, Estazolam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9115known
D00311, Estazolam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9113known
D00499, Pentobarbital hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.9112known
D00499, Pentobarbital hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.9107known
D00329, Flurazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9101known
D00499, Pentobarbital hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.91known
D00430, Secobarbital hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.91known
D00280, Clonazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9085known
D00499, Pentobarbital hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.9085known
D00280, Clonazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9083known
D00499, Pentobarbital hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.9077known
D00457, Quazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9077known
D00499, Pentobarbital hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.9057known
D00499, Pentobarbital hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.9052known
D00311, Estazolam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9041known
D00470, Prazepam hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.9014known
D00280, Clonazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.9011known
D00470, Prazepam hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.9011known
D00430, Secobarbital hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.8994known
D00430, Secobarbital hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.8992known
D00499, Pentobarbital hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.8988known
D00499, Pentobarbital hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.8967known
D00470, Prazepam hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.894known
D00499, Pentobarbital hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.8936known
D00267, Chlordiazepoxide hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.8925known
D00430, Secobarbital hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.8921known
D00267, Chlordiazepoxide hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.89known
D00267, Chlordiazepoxide hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.8892known
D00283, Clozapine hsa:3358, (RefSeq) 5-hydroxytryptamine receptor 2C0.8889known
D00267, Chlordiazepoxide hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.8882known
D00267, Chlordiazepoxide hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.8879known
D00267, Chlordiazepoxide hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.8864known
D00267, Chlordiazepoxide hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.8857known
D00499, Pentobarbital hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.8838known
D00499, Pentobarbital hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.8836known
D00267, Chlordiazepoxide hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.8834known
D00267, Chlordiazepoxide hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.8829known
D00458, Quetiapine fumarate hsa:1813, (RefSeq) dopamine receptor D20.8777known
D00267, Chlordiazepoxide hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.8767known
D00499, Pentobarbital hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.8767known
D00270, Chlorpromazine hsa:1813, (RefSeq) dopamine receptor D20.8749known
D00267, Chlordiazepoxide hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.8746known
D00267, Chlordiazepoxide hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.8718known
D00304, Divalproex sodium hsa:253175, (RefSeq) chromodomain Y-linked 1B0.868known
D00432, Nadolol hsa:153, (RefSeq) adrenoceptor beta 10.8678known
D00426, Risperidone hsa:1813, (RefSeq) dopamine receptor D20.8677known
D00304, Divalproex sodium hsa:203611, (RefSeq) chromodomain Y-linked 2B0.8676known
D00376, Meprobamate hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.8664known
D00376, Meprobamate hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.8656known
D00458, Quetiapine fumarate hsa:147, (RefSeq) adrenoceptor alpha 1B0.8654known
D00376, Meprobamate hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.8654known
D00185, Estriol hsa:2099, (RefSeq) estrogen receptor 10.8647known
D00454, Olanzapine hsa:1813, (RefSeq) dopamine receptor D20.8646known
D00376, Meprobamate hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.8645known
D00185, Estriol hsa:2100, (RefSeq) estrogen receptor 20.8641known
D00138, Scopolamine hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.863known
D00376, Meprobamate hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.8629known
D00376, Meprobamate hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.8623known
D00454, Olanzapine hsa:1815, (RefSeq) dopamine receptor D40.8621known
D00267, Chlordiazepoxide hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.862known
D00267, Chlordiazepoxide hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.8618known
D00138, Scopolamine hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8617known
D00376, Meprobamate hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.8613known
D00407, Methylprednisolone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.861known
D00138, Scopolamine hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.86known
D00378, Timolol hsa:153, (RefSeq) adrenoceptor beta 10.8596known
D00138, Scopolamine hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8595known
D00403, Methotrimeprazine hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.8595known
D00147, Hyoscyamine hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8584known
D00131, Disulfiram hsa:219, (RefSeq) aldehyde dehydrogenase 1 family member B10.8575known
D00131, Disulfiram hsa:217, (RefSeq) aldehyde dehydrogenase 2 family member0.8571known
D00472, Prednisolone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8567known
D00376, Meprobamate hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.8564known
D00383, Trandolapril hsa:1636, (RefSeq) angiotensin I converting enzyme0.8564known
D00088, Hydrocortisone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8562known
D00376, Meprobamate hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.856known
D00147, Hyoscyamine hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.856known
D00458, Quetiapine fumarate hsa:148, (RefSeq) adrenoceptor alpha 1A0.8559known
D00216, Acarbose hsa:280, (RefSeq) amylase alpha 2B0.8557known
D00216, Acarbose hsa:279, (RefSeq) amylase alpha 2A0.8556known
D00267, Chlordiazepoxide hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.855known
D00270, Chlorpromazine hsa:3358, (RefSeq) 5-hydroxytryptamine receptor 2C0.8541known
D00147, Hyoscyamine hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8528known
D00147, Hyoscyamine hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.8527known
D00399, Valproic acid hsa:253175, (RefSeq) chromodomain Y-linked 1B0.8522known
D00399, Valproic acid hsa:203611, (RefSeq) chromodomain Y-linked 2B0.8519known
D00479, Prochlorperazine maleate hsa:1813, (RefSeq) dopamine receptor D20.8501known
D00376, Meprobamate hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.8499known
D00113, Atropine hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8498known
D00376, Meprobamate hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.8487known
D00113, Atropine hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.8484known
D00458, Quetiapine fumarate hsa:146, (RefSeq) adrenoceptor alpha 1D0.8481known
D00376, Meprobamate hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.8479known
D00359, Lovastatin hsa:3156, (RefSeq) 3-hydroxy-3-methylglutaryl-CoA reductase0.8463known
D00426, Risperidone hsa:147, (RefSeq) adrenoceptor alpha 1B0.8462known
D00113, Atropine hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.8457known
D00325, Fluocinonide hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8455known
D00113, Atropine hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8446known
D00216, Acarbose hsa:2595, (RefSeq) glucosidase alpha0.842known
D00283, Clozapine hsa:147, (RefSeq) adrenoceptor alpha 1B0.8419known
D00216, Acarbose hsa:2548, (RefSeq) alpha glucosidase0.8419known
D00454, Olanzapine hsa:147, (RefSeq) adrenoceptor alpha 1B0.8411known
D00255, Carvedilol hsa:153, (RefSeq) adrenoceptor beta 10.8384known
D00165, Hydrocortisone acetate hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8378known
D00481, Propantheline bromide hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8376known
D00473, Prednisone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8365known
D00376, Meprobamate hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.8358known
D00376, Meprobamate hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.8356known
D00244, Betamethasone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8352known
D00421, Ramipril hsa:1636, (RefSeq) angiotensin I converting enzyme0.8347known
D00481, Propantheline bromide hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.8343known
D00251, Captopril hsa:1636, (RefSeq) angiotensin I converting enzyme0.8341known
D00270, Chlorpromazine hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8337known
D00131, Disulfiram hsa:224, (RefSeq) aldehyde dehydrogenase 3 family member A20.833known
D00138, Scopolamine hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.833known
D00454, Olanzapine hsa:148, (RefSeq) adrenoceptor alpha 1A0.832known
D00227, Aminophylline hsa:135, (RefSeq) adenosine A2a receptor0.8316known
D00371, Theophylline hsa:135, (RefSeq) adenosine A2a receptor0.8316known
D00481, Propantheline bromide hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.8312known
D00481, Propantheline bromide hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8308known
D00095, Epinephrine hsa:155, (RefSeq) adrenoceptor beta 30.8307known
D00246, Budesonide hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8306known
D00483, Propranolol hydrochloride hsa:153, (RefSeq) adrenoceptor beta 10.8304known
D00362, Lisinopril hsa:1636, (RefSeq) angiotensin I converting enzyme0.8295known
D00147, Hyoscyamine hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.8291known
D00376, Meprobamate hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.8291known
D00397, Tropicamide hsa:1132, (RefSeq) cholinergic receptor muscarinic 40.8285known
D00283, Clozapine hsa:148, (RefSeq) adrenoceptor alpha 1A0.8285known
D00385, Triamcinolone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8278known
D00403, Methotrimeprazine hsa:1813, (RefSeq) dopamine receptor D20.8275known
D00095, Epinephrine hsa:147, (RefSeq) adrenoceptor alpha 1B0.8266known
D00304, Divalproex sodium hsa:18, (RefSeq) 4-aminobutyrate aminotransferase0.8261known
D00397, Tropicamide hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.826known
D00454, Olanzapine hsa:146, (RefSeq) adrenoceptor alpha 1D0.8252known
D00434, Simvastatin hsa:3156, (RefSeq) 3-hydroxy-3-methylglutaryl-CoA reductase0.8245known
D00426, Risperidone hsa:146, (RefSeq) adrenoceptor alpha 1D0.8244known
D00397, Tropicamide hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.8232known
D00283, Clozapine hsa:146, (RefSeq) adrenoceptor alpha 1D0.8228known
D00283, Clozapine hsa:1813, (RefSeq) dopamine receptor D20.8225known
D00397, Tropicamide hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8224known
D00113, Atropine hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.8219known
D00491, Paclitaxel hsa:10383, (RefSeq) tubulin beta 4B class IVb0.8218known
D00076, Noradrenaline hsa:155, (RefSeq) adrenoceptor beta 30.82known
D00456, Ondansetron hsa:285242, (RefSeq) 5-hydroxytryptamine receptor 3E0.8198known
D00491, Paclitaxel hsa:10382, (RefSeq) tubulin beta 4A class IVa0.8197known
D00491, Paclitaxel hsa:203068, (RefSeq) tubulin beta class I0.819known
D00324, Flunisolide hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8187known
D00227, Aminophylline hsa:134, (RefSeq) adenosine A1 receptor0.8185known
D00371, Theophylline hsa:134, (RefSeq) adenosine A1 receptor0.8177known
D00374, Thiothixene hsa:1813, (RefSeq) dopamine receptor D20.8176known
D00426, Risperidone hsa:148, (RefSeq) adrenoceptor alpha 1A0.8173known
D00155, Pentostatin hsa:100, (RefSeq) adenosine deaminase0.8151known
D00136, Haloperidol hsa:1813, (RefSeq) dopamine receptor D20.8135known
D00076, Noradrenaline hsa:147, (RefSeq) adrenoceptor alpha 1B0.8134known
D00414, Zileuton hsa:240, (RefSeq) arachidonate 5-lipoxygenase0.8129known
D00219, Acetohexamide hsa:10060, (RefSeq) ATP binding cassette subfamily C member 90.8126known
D00124, Ephedrine hsa:155, (RefSeq) adrenoceptor beta 30.8123known
D00095, Epinephrine hsa:151, (RefSeq) adrenoceptor alpha 2B0.8122known
D00485, Pseudoephedrine hydrochloride hsa:155, (RefSeq) adrenoceptor beta 30.8122known
D00095, Epinephrine hsa:146, (RefSeq) adrenoceptor alpha 1D0.8117known
D00399, Valproic acid hsa:18, (RefSeq) 4-aminobutyrate aminotransferase0.8113known
D00095, Epinephrine hsa:150, (RefSeq) adrenoceptor alpha 2A0.81known
D00405, Methyldopa hsa:150, (RefSeq) adrenoceptor alpha 2A0.8098known
D00481, Propantheline bromide hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.8096known
D00270, Chlorpromazine hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.8095known
D00095, Epinephrine hsa:154, (RefSeq) adrenoceptor beta 20.8094known
D00076, Noradrenaline hsa:151, (RefSeq) adrenoceptor alpha 2B0.8083known
D00405, Methyldopa hsa:151, (RefSeq) adrenoceptor alpha 2B0.8077known
D00328, Flurandrenolide hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.8068known
D00095, Epinephrine hsa:148, (RefSeq) adrenoceptor alpha 1A0.8066known
D00076, Noradrenaline hsa:150, (RefSeq) adrenoceptor alpha 2A0.8062known
D00485, Pseudoephedrine hydrochloride hsa:147, (RefSeq) adrenoceptor alpha 1B0.8059known
D00456, Ondansetron hsa:170572, (RefSeq) 5-hydroxytryptamine receptor 3C0.8055known
D00493, Prochlorperazine hsa:1813, (RefSeq) dopamine receptor D20.8054known
D00335, Glipizide hsa:10060, (RefSeq) ATP binding cassette subfamily C member 90.8045known
D00458, Quetiapine fumarate hsa:1814, (RefSeq) dopamine receptor D30.8041known
D00270, Chlorpromazine hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.8039known
D00456, Ondansetron hsa:200909, (RefSeq) 5-hydroxytryptamine receptor 3D0.8037known
D00124, Ephedrine hsa:147, (RefSeq) adrenoceptor alpha 1B0.8031known
D00459, Quinapril hydrochloride hsa:1636, (RefSeq) angiotensin I converting enzyme0.8022known
D00181, Argatroban hsa:2147, (RefSeq) coagulation factor II0.8021known
D00397, Tropicamide hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.8011known
D00410, Metyrapone hsa:1584, (RefSeq) cytochrome P450 family 11 subfamily B member 10.8008known
D00095, Epinephrine hsa:153, (RefSeq) adrenoceptor beta 10.8known
D00491, Paclitaxel hsa:10381, (RefSeq) tubulin beta 3 class III0.8known
D00485, Pseudoephedrine hydrochloride hsa:151, (RefSeq) adrenoceptor alpha 2B0.7991known
D00076, Noradrenaline hsa:154, (RefSeq) adrenoceptor beta 20.7989known
D00076, Noradrenaline hsa:146, (RefSeq) adrenoceptor alpha 1D0.7987known
D00485, Pseudoephedrine hydrochloride hsa:150, (RefSeq) adrenoceptor alpha 2A0.7968known
D00331, Furosemide hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.7962known
D00270, Chlorpromazine hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.7955known
D00271, Chlorpropamide hsa:10060, (RefSeq) ATP binding cassette subfamily C member 90.7952known
D00331, Furosemide hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.7951known
D00306, Dronabinol hsa:1268, (RefSeq) cannabinoid receptor 10.794known
D00076, Noradrenaline hsa:148, (RefSeq) adrenoceptor alpha 1A0.7933known
D00124, Ephedrine hsa:151, (RefSeq) adrenoceptor alpha 2B0.793known
D00403, Methotrimeprazine hsa:151, (RefSeq) adrenoceptor alpha 2B0.7929known
D00485, Pseudoephedrine hydrochloride hsa:154, (RefSeq) adrenoceptor beta 20.7917known
D00485, Pseudoephedrine hydrochloride hsa:146, (RefSeq) adrenoceptor alpha 1D0.7914known
D00124, Ephedrine hsa:154, (RefSeq) adrenoceptor beta 20.7913known
D00373, Thioridazine hsa:1813, (RefSeq) dopamine receptor D20.7911known
D00124, Ephedrine hsa:150, (RefSeq) adrenoceptor alpha 2A0.7908known
D00331, Furosemide hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.7904known
D00292, Dexamethasone hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.7903known
D00270, Chlorpromazine hsa:1133, (RefSeq) cholinergic receptor muscarinic 50.7893known
D00076, Noradrenaline hsa:153, (RefSeq) adrenoceptor beta 10.7893known
D00454, Olanzapine hsa:3269, (RefSeq) histamine receptor H10.7887known
D00124, Ephedrine hsa:146, (RefSeq) adrenoceptor alpha 1D0.7885known
D00270, Chlorpromazine hsa:151, (RefSeq) adrenoceptor alpha 2B0.7884known
D00331, Furosemide hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.788known
D00403, Methotrimeprazine hsa:150, (RefSeq) adrenoceptor alpha 2A0.7874known
D00293, Diazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7871training - new
D00458, Quetiapine fumarate hsa:3269, (RefSeq) histamine receptor H10.7867known
D00270, Chlorpromazine hsa:3269, (RefSeq) histamine receptor H10.7866known
D00485, Pseudoephedrine hydrochloride hsa:148, (RefSeq) adrenoceptor alpha 1A0.7864known
D00312, Estrone sodium sulfatehsa:2099, (RefSeq) estrogen receptor 10.7862known
D00095, Epinephrine hsa:152, (RefSeq) adrenoceptor alpha 2C0.7861known
D00312, Estrone sodium sulfatehsa:2100, (RefSeq) estrogen receptor 20.7857known
D00059, Levodopa hsa:1813, (RefSeq) dopamine receptor D20.7855known
D00270, Chlorpromazine hsa:150, (RefSeq) adrenoceptor alpha 2A0.7851known
D00379, Tolazamide hsa:10060, (RefSeq) ATP binding cassette subfamily C member 90.7846known
D00142, Methotrexate hsa:1719, (RefSeq) dihydrofolate reductase0.7831known
D00124, Ephedrine hsa:148, (RefSeq) adrenoceptor alpha 1A0.783known
D00076, Noradrenaline hsa:152, (RefSeq) adrenoceptor alpha 2C0.7823known
D00405, Methyldopa hsa:152, (RefSeq) adrenoceptor alpha 2C0.7809known
D00124, Ephedrine hsa:153, (RefSeq) adrenoceptor beta 10.7807known
D00485, Pseudoephedrine hydrochloride hsa:153, (RefSeq) adrenoceptor beta 10.7799known
D00403, Methotrimeprazine hsa:147, (RefSeq) adrenoceptor alpha 1B0.7791known
D00283, Clozapine hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.7789known
D00255, Carvedilol hsa:155, (RefSeq) adrenoceptor beta 30.7779known
D00420, Mitotane hsa:1586, (RefSeq) cytochrome P450 family 17 subfamily A member 10.7777known
D00059, Levodopa hsa:1812, (RefSeq) dopamine receptor D10.7757known
D00403, Methotrimeprazine hsa:3358, (RefSeq) 5-hydroxytryptamine receptor 2C0.7752known
D00281, Clonidine hsa:150, (RefSeq) adrenoceptor alpha 2A0.7741known
D00152, Phloroglucinol hsa:1312, (RefSeq) catechol-O-methyltransferase0.7736known
D00281, Clonidine hsa:151, (RefSeq) adrenoceptor alpha 2B0.7733known
D00485, Pseudoephedrine hydrochloride hsa:152, (RefSeq) adrenoceptor alpha 2C0.7733known
D00494, Promethazine hsa:3269, (RefSeq) histamine receptor H10.771known
D00059, Levodopa hsa:1814, (RefSeq) dopamine receptor D30.7696known
D00465, Oxybutynin hsa:1128, (RefSeq) cholinergic receptor muscarinic 10.7693known
D00308, Droperidol hsa:1813, (RefSeq) dopamine receptor D20.7674known
D00124, Ephedrine hsa:152, (RefSeq) adrenoceptor alpha 2C0.7673known
D00403, Methotrimeprazine hsa:152, (RefSeq) adrenoceptor alpha 2C0.7669known
D00270, Chlorpromazine hsa:3357, (RefSeq) 5-hydroxytryptamine receptor 2B0.7665known
D00331, Furosemide hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.7654known
D00365, Lorazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7652training - new
D00241, Baclofen hsa:2550, (RefSeq) gamma-aminobutyric acid type B receptor subunit 10.7646known
D00370, Temazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7643training - new
D00415, Zolmitriptan hsa:3352, (RefSeq) 5-hydroxytryptamine receptor 1D0.7641known
D00415, Zolmitriptan hsa:3351, (RefSeq) 5-hydroxytryptamine receptor 1B0.7632known
D00465, Oxybutynin hsa:1131, (RefSeq) cholinergic receptor muscarinic 30.763known
D00432, Nadolol hsa:155, (RefSeq) adrenoceptor beta 30.7625known
D00270, Chlorpromazine hsa:152, (RefSeq) adrenoceptor alpha 2C0.7623known
D00387, Triazolam hsa:2741, (RefSeq) glycine receptor alpha 10.7618training - new
D00331, Furosemide hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.7614known
D00378, Timolol hsa:155, (RefSeq) adrenoceptor beta 30.761known
D00306, Dronabinol hsa:1269, (RefSeq) cannabinoid receptor 20.7607known
D00255, Carvedilol hsa:147, (RefSeq) adrenoceptor alpha 1B0.7601known
D00480, Promethazine hydrochloride hsa:3269, (RefSeq) histamine receptor H10.7596known
D00451, Sumatriptan hsa:3352, (RefSeq) 5-hydroxytryptamine receptor 1D0.7595known
D00270, Chlorpromazine hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.7591known
D00403, Methotrimeprazine hsa:146, (RefSeq) adrenoceptor alpha 1D0.7589known
D00451, Sumatriptan hsa:3351, (RefSeq) 5-hydroxytryptamine receptor 1B0.7586known
D00225, Alprazolam hsa:2741, (RefSeq) glycine receptor alpha 10.7576training - new
D00283, Clozapine hsa:1815, (RefSeq) dopamine receptor D40.7573known
D00465, Oxybutynin hsa:1129, (RefSeq) cholinergic receptor muscarinic 20.7558known
D00454, Olanzapine hsa:1814, (RefSeq) dopamine receptor D30.7557known
D00440, Nizatidine hsa:3274, (RefSeq) histamine receptor H20.7553known
D00234, Astemizole hsa:3269, (RefSeq) histamine receptor H10.7544known
D00255, Carvedilol hsa:154, (RefSeq) adrenoceptor beta 20.7537known
D00432, Nadolol hsa:154, (RefSeq) adrenoceptor beta 20.7517known
D00156, Glycyrrhetinic acid hsa:3290, (RefSeq) hydroxysteroid 11-beta dehydrogenase 10.751known
D00378, Timolol hsa:154, (RefSeq) adrenoceptor beta 20.7503known
D00255, Carvedilol hsa:146, (RefSeq) adrenoceptor alpha 1D0.7483known
D00403, Methotrimeprazine hsa:148, (RefSeq) adrenoceptor alpha 1A0.7477known
D00329, Flurazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7464training - new
D00281, Clonidine hsa:152, (RefSeq) adrenoceptor alpha 2C0.7462known
D00457, Quazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7438training - new
D00295, Cimetidine hsa:3274, (RefSeq) histamine receptor H20.743known
D00311, Estazolam hsa:2741, (RefSeq) glycine receptor alpha 10.7426training - new
D00364, Loratadine hsa:3269, (RefSeq) histamine receptor H10.7419known
D00318, Famotidine hsa:3274, (RefSeq) histamine receptor H20.7415known
D00492, Pancuronium bromide hsa:1146, (RefSeq) cholinergic receptor nicotinic gamma subunit0.7415known
D00105, Estradiol hsa:2099, (RefSeq) estrogen receptor 10.7395known
D00105, Estradiol hsa:2100, (RefSeq) estrogen receptor 20.7389known
D00255, Carvedilol hsa:148, (RefSeq) adrenoceptor alpha 1A0.7386known
D00280, Clonazepam hsa:2741, (RefSeq) glycine receptor alpha 10.738training - new
D00059, Levodopa hsa:1815, (RefSeq) dopamine receptor D40.7358known
D00492, Pancuronium bromide hsa:1145, (RefSeq) cholinergic receptor nicotinic epsilon subunit0.7353known
D00422, Ranitidine hsa:3274, (RefSeq) histamine receptor H20.7349known
D00470, Prazepam hsa:2741, (RefSeq) glycine receptor alpha 10.7334training - new
D00483, Propranolol hydrochloride hsa:155, (RefSeq) adrenoceptor beta 30.733known
D00357, Losartan potassium hsa:185, (RefSeq) angiotensin II receptor type 10.732known
D00458, Quetiapine fumarate hsa:1815, (RefSeq) dopamine receptor D40.7319known
D00430, Secobarbital hsa:2741, (RefSeq) glycine receptor alpha 10.7314training - new
D00492, Pancuronium bromide hsa:1144, (RefSeq) cholinergic receptor nicotinic delta subunit0.7264known
D00293, Diazepam hsa:2742, (RefSeq) glycine receptor alpha 20.7253training - new
D00483, Propranolol hydrochloride hsa:154, (RefSeq) adrenoceptor beta 20.7221known
D00400, Valsartan hsa:185, (RefSeq) angiotensin II receptor type 10.721known
D00499, Pentobarbital hsa:2741, (RefSeq) glycine receptor alpha 10.7185training - new
D00458, Quetiapine fumarate hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.7169known
D00492, Pancuronium bromide hsa:1140, (RefSeq) cholinergic receptor nicotinic beta 1 subunit0.7124known
D00365, Lorazepam hsa:2742, (RefSeq) glycine receptor alpha 20.7053training - new
D00370, Temazepam hsa:2742, (RefSeq) glycine receptor alpha 20.7043training - new
D00387, Triazolam hsa:2742, (RefSeq) glycine receptor alpha 20.7022training - new
D00267, Chlordiazepoxide hsa:2741, (RefSeq) glycine receptor alpha 10.7005training - new
D00403, Methotrimeprazine hsa:3357, (RefSeq) 5-hydroxytryptamine receptor 2B0.6981known
D00225, Alprazolam hsa:2742, (RefSeq) glycine receptor alpha 20.6981training - new
D00283, Clozapine hsa:3350, (RefSeq) 5-hydroxytryptamine receptor 1A0.6968known
D00329, Flurazepam hsa:2742, (RefSeq) glycine receptor alpha 20.688training - new
D00457, Quazepam hsa:2742, (RefSeq) glycine receptor alpha 20.6856training - new
D00311, Estazolam hsa:2742, (RefSeq) glycine receptor alpha 20.6845training - new
D00280, Clonazepam hsa:2742, (RefSeq) glycine receptor alpha 20.6804training - new
D00376, Meprobamate hsa:2741, (RefSeq) glycine receptor alpha 10.6803training - new
D00470, Prazepam hsa:2742, (RefSeq) glycine receptor alpha 20.6759training - new
D00430, Secobarbital hsa:2742, (RefSeq) glycine receptor alpha 20.6739training - new
D00300, Diphenhydramine hsa:3269, (RefSeq) histamine receptor H10.6694known
D00499, Pentobarbital hsa:2742, (RefSeq) glycine receptor alpha 20.6624training - new
D00492, Pancuronium bromide hsa:1134, (RefSeq) cholinergic receptor nicotinic alpha 1 subunit0.6622known
D00267, Chlordiazepoxide hsa:2742, (RefSeq) glycine receptor alpha 20.6457training - new
D00454, Olanzapine hsa:3358, (RefSeq) 5-hydroxytryptamine receptor 2C0.644known
D00376, Meprobamate hsa:2742, (RefSeq) glycine receptor alpha 20.6271training - new
D00405, Methyldopa hsa:1644, (RefSeq) dopa decarboxylase0.6154known
D00374, Thiothixene hsa:1812, (RefSeq) dopamine receptor D10.6148known
D00059, Levodopa hsa:1816, (RefSeq) dopamine receptor D50.6125known
D00293, Diazepam hsa:2743, (RefSeq) glycine receptor beta0.5939training - new
D00426, Risperidone hsa:3356, (RefSeq) 5-hydroxytryptamine receptor 2A0.5927known
D00365, Lorazepam hsa:2743, (RefSeq) glycine receptor beta0.5778training - new
D00370, Temazepam hsa:2743, (RefSeq) glycine receptor beta0.577training - new
D00387, Triazolam hsa:2743, (RefSeq) glycine receptor beta0.5752training - new
D00225, Alprazolam hsa:2743, (RefSeq) glycine receptor beta0.5716training - new
D00329, Flurazepam hsa:2743, (RefSeq) glycine receptor beta0.5636training - new
D00457, Quazepam hsa:2743, (RefSeq) glycine receptor beta0.5616training - new
D00311, Estazolam hsa:2743, (RefSeq) glycine receptor beta0.5605training - new
D00280, Clonazepam hsa:2743, (RefSeq) glycine receptor beta0.5571training - new
D00470, Prazepam hsa:2743, (RefSeq) glycine receptor beta0.5538training - new
D00430, Secobarbital hsa:2743, (RefSeq) glycine receptor beta0.5522training - new
D00499, Pentobarbital hsa:2743, (RefSeq) glycine receptor beta0.5424training - new
D00267, Chlordiazepoxide hsa:2743, (RefSeq) glycine receptor beta0.5285training - new
D00376, Meprobamate hsa:2743, (RefSeq) glycine receptor beta0.5132training - new
D00235, Atenolol hsa:153, (RefSeq) adrenoceptor beta 10.466known
D00178, Octopamine hydrochloride hsa:151, (RefSeq) adrenoceptor alpha 2B0.4053new - training
D00178, Octopamine hydrochloride hsa:150, (RefSeq) adrenoceptor alpha 2A0.4053new - training
D00035, Proline hsa:1636, (RefSeq) angiotensin I converting enzyme0.3992new - training
D00178, Octopamine hydrochloride hsa:152, (RefSeq) adrenoceptor alpha 2C0.3923new - training
D00044, Maltose hsa:280, (RefSeq) amylase alpha 2B0.364new - training
D00044, Maltose hsa:279, (RefSeq) amylase alpha 2A0.3638new - training
D00044, Maltose hsa:2595, (RefSeq) glucosidase alpha0.3581new - training
D00044, Maltose hsa:2548, (RefSeq) alpha glucosidase0.358new - training
D00046, Anhydrous lactose hsa:280, (RefSeq) amylase alpha 2B0.3537new - training
D00046, Anhydrous lactose hsa:279, (RefSeq) amylase alpha 2A0.3535new - training
D00084, Dextrin hsa:280, (RefSeq) amylase alpha 2B0.3527new - training
D00084, Dextrin hsa:279, (RefSeq) amylase alpha 2A0.3525new - training
D00046, Anhydrous lactose hsa:2595, (RefSeq) glucosidase alpha0.3479new - training
D00046, Anhydrous lactose hsa:2548, (RefSeq) alpha glucosidase0.3479new - training
D00084, Dextrin hsa:2595, (RefSeq) glucosidase alpha0.347new - training
D00084, Dextrin hsa:2548, (RefSeq) alpha glucosidase0.3469new - training
D00160, Aminocaproic acid hsa:253175, (RefSeq) chromodomain Y-linked 1B0.3389new - training
D00160, Aminocaproic acid hsa:203611, (RefSeq) chromodomain Y-linked 2B0.3385new - training
D00099, Cetanol hsa:2566, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma20.3227new - training
D00160, Aminocaproic acid hsa:18, (RefSeq) 4-aminobutyrate aminotransferase0.3222new - training
D00099, Cetanol hsa:2565, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma10.3213new - training
D00107, Tacrolimus hsa:2908, (RefSeq) nuclear receptor subfamily 3 group C member 10.3206new - training
D00099, Cetanol hsa:2560, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta10.3197new - training
D00099, Cetanol hsa:2561, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta20.3197new - training
D00099, Cetanol hsa:2562, (RefSeq) gamma-aminobutyric acid type A receptor subunit beta30.3182new - training
D00099, Cetanol hsa:2567, (RefSeq) gamma-aminobutyric acid type A receptor subunit gamma30.3174new - training
D00099, Cetanol hsa:2558, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha50.313new - training
D00099, Cetanol hsa:2555, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha20.3126new - training
D00099, Cetanol hsa:2554, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha10.3123new - training
D00099, Cetanol hsa:2559, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha60.3119new - training
D00099, Cetanol hsa:2564, (RefSeq) gamma-aminobutyric acid type A receptor subunit epsilon0.3119new - training
D00099, Cetanol hsa:2556, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha30.3115new - training
D00099, Cetanol hsa:2563, (RefSeq) gamma-aminobutyric acid type A receptor subunit delta0.3114new - training
D00099, Cetanol hsa:2568, (RefSeq) gamma-aminobutyric acid type A receptor subunit pi0.3091new - training
D00099, Cetanol hsa:2557, (RefSeq) gamma-aminobutyric acid type A receptor subunit alpha40.3065new - training